메뉴 건너뛰기




Volumn 30, Issue 4, 2011, Pages 341-354

MET and phosphorylated MET as potential biomarkers in lung cancer

Author keywords

Hepatocyte growth factor (HGF); Lung cancer; Phosphorylated MET; Tyrosine kinase MET

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOPROTEIN; PHOSPHORYLATED MET; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

EID: 83455234750     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v30.i4.70     Document Type: Article
Times cited : (29)

References (50)
  • 3
    • 69349088824 scopus 로고    scopus 로고
    • Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials
    • Jackman DM, Miller VA, Cioffredi LA, Yeap BY, Jänne PA, Riely GJ, Ruiz MG, Giaccone G, Sequist LV, Johnson BE. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials. Clin Cancer Res. 2009;15(16):5267-73.
    • (2009) Clin Cancer Res , vol.15 , Issue.16 , pp. 5267-5273
    • Jackman, D.M.1    Miller, V.A.2    Cioffredi, L.A.3    Yeap, B.Y.4    Jänne, P.A.5    Riely, G.J.6    Ruiz, M.G.7    Giaccone, G.8    Sequist, L.V.9    Johnson, B.E.10
  • 7
    • 0030989021 scopus 로고    scopus 로고
    • Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
    • Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer. 1997;79(7):1329-37.
    • (1997) Cancer , vol.79 , Issue.7 , pp. 1329-1337
    • Dosaka-Akita, H.1    Hu, S.X.2    Fujino, M.3    Harada, M.4    Kinoshita, I.5    Xu, H.J.6    Kuzumaki, N.7    Kawakami, Y.8    Benedict, W.F.9
  • 9
    • 0032926002 scopus 로고    scopus 로고
    • Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers
    • Geradts J, Fong KM, Zimmerman PV, Maynard R, Minna JD. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers. Clin Cancer Res. 1999;5(4):791-800.
    • (1999) Clin Cancer Res , vol.5 , Issue.4 , pp. 791-800
    • Geradts, J.1    Fong, K.M.2    Zimmerman, P.V.3    Maynard, R.4    Minna, J.D.5
  • 11
    • 23244461458 scopus 로고    scopus 로고
    • Selective reporting biases in cancer prognostic factor studies
    • Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97(14):1043-55.
    • (2005) J Natl Cancer Inst , vol.97 , Issue.14 , pp. 1043-1055
    • Kyzas, P.A.1    Loizou, K.T.2    Ioannidis, J.P.3
  • 12
    • 0028318390 scopus 로고
    • Statistical aspects of prognostic factor studies in oncology
    • Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994;69(6):979-85.
    • (1994) Br J Cancer , vol.69 , Issue.6 , pp. 979-985
    • Simon, R.1    Altman, D.G.2
  • 13
    • 64949190936 scopus 로고    scopus 로고
    • Prognostic markers in cancer: The evolution of evidence from single studies to meta-analysis, and beyond
    • Riley RD, Sauerbrei W, Altman DG. Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer. 2009;100(8):1219-29.
    • (2009) Br J Cancer , vol.100 , Issue.8 , pp. 1219-1229
    • Riley, R.D.1    Sauerbrei, W.2    Altman, D.G.3
  • 14
    • 0027348905 scopus 로고
    • Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells
    • Comoglio PM. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS. 1993;65:131-65.
    • (1993) EXS , vol.65 , pp. 131-165
    • Comoglio, P.M.1
  • 15
    • 0030112519 scopus 로고    scopus 로고
    • The HGF receptor family: Unconventional signal transducers for invasive cell growth
    • Comoglio PM, Boccaccio C. The HGF receptor family: unconventional signal transducers for invasive cell growth. Genes Cells. 1996;1(4):347-54.
    • (1996) Genes Cells , vol.1 , Issue.4 , pp. 347-354
    • Comoglio, P.M.1    Boccaccio, C.2
  • 17
    • 38849116986 scopus 로고    scopus 로고
    • Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization
    • Samuelson E, Levan K, Adamovic T, Levan G, Horvath G. Recurrent gene amplifications in human type I endometrial adenocarcinoma detected by fluorescence in situ hybridization. Cancer Genet Cytogenet. 2008;181(1):25-30.
    • (2008) Cancer Genet Cytogenet , vol.181 , Issue.1 , pp. 25-30
    • Samuelson, E.1    Levan, K.2    Adamovic, T.3    Levan, G.4    Horvath, G.5
  • 20
    • 0031657056 scopus 로고    scopus 로고
    • Amplification of c-myc, K-sam, and c-met in gastric cancers: Detection by fluorescence in situ hybridization
    • Hara T, Ooi A, Kobayashi M, Mai M, Yanagihara K, Nakanishi I. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Lab Invest. 1998;78(9):1143-53.
    • (1998) Lab Invest , vol.78 , Issue.9 , pp. 1143-1153
    • Hara, T.1    Ooi, A.2    Kobayashi, M.3    Mai, M.4    Yanagihara, K.5    Nakanishi, I.6
  • 22
    • 67649393456 scopus 로고    scopus 로고
    • MET pathway as a therapeutic target
    • Kim ES, Salgia R. MET pathway as a therapeutic target. J Thorac Oncol. 2009;4(4):444-7.
    • (2009) J Thorac Oncol , vol.4 , Issue.4 , pp. 444-447
    • Kim, E.S.1    Salgia, R.2
  • 23
    • 19544389146 scopus 로고    scopus 로고
    • c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention
    • Christensen JG, Burrows J, Salgia R. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Lett. 2005;225(1):1-26.
    • (2005) Cancer Lett , vol.225 , Issue.1 , pp. 1-26
    • Christensen, J.G.1    Burrows, J.2    Salgia, R.3
  • 24
    • 0038724909 scopus 로고    scopus 로고
    • c-Met: Structure, functions and potential for therapeutic inhibition
    • Ma PC, Maulik G, Christensen J, Salgia R. c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 2003;22(4):309-25.
    • (2003) Cancer Metastasis Rev , vol.22 , Issue.4 , pp. 309-325
    • Ma, P.C.1    Maulik, G.2    Christensen, J.3    Salgia, R.4
  • 25
    • 0035930341 scopus 로고    scopus 로고
    • Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein
    • Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell. 2001;8(5):995-1004.
    • (2001) Mol Cell , vol.8 , Issue.5 , pp. 995-1004
    • Peschard, P.1    Fournier, T.M.2    Lamorte, L.3    Naujokas, M.A.4    Band, H.5    Langdon, W.Y.6    Park, M.7
  • 27
    • 70350094241 scopus 로고    scopus 로고
    • MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance
    • Kanteti R, Yala S, Ferguson MK, Salgia R. MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance. J Environ Pathol Toxicol Oncol. 2009;28(2):89-98.
    • (2009) J Environ Pathol Toxicol Oncol , vol.28 , Issue.2 , pp. 89-98
    • Kanteti, R.1    Yala, S.2    Ferguson, M.K.3    Salgia, R.4
  • 28
    • 0029803612 scopus 로고    scopus 로고
    • Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance
    • Ichimura E, Maeshima A, Nakajima T, Nakamura T. Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. Jpn J Cancer Res. 1996;87(10):1063-9.
    • (1996) Jpn J Cancer Res , vol.87 , Issue.10 , pp. 1063-1069
    • Ichimura, E.1    Maeshima, A.2    Nakajima, T.3    Nakamura, T.4
  • 29
    • 2442513981 scopus 로고    scopus 로고
    • The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients
    • Masuya D, Huang C, Liu D, Nakashima T, Kameyama K, Haba R, Ueno M, Yokomise H. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients. Br J Cancer. 2004;90(8):1555-62.
    • (2004) Br J Cancer , vol.90 , Issue.8 , pp. 1555-1562
    • Masuya, D.1    Huang, C.2    Liu, D.3    Nakashima, T.4    Kameyama, K.5    Haba, R.6    Ueno, M.7    Yokomise, H.8
  • 31
    • 0031057905 scopus 로고    scopus 로고
    • Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
    • Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res. 1997;57(3):433-9.
    • (1997) Cancer Res , vol.57 , Issue.3 , pp. 433-439
    • Siegfried, J.M.1    Weissfeld, L.A.2    Singh-Kaw, P.3    Weyant, R.J.4    Testa, J.R.5    Landreneau, R.J.6
  • 33
    • 34547558390 scopus 로고    scopus 로고
    • Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: Implications for tumour invasion
    • Ma PC, Tretiakova MS, Nallasura V, Jagadeeswaran R, Husain AN, Salgia R. Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion. Br J Cancer. 2007;97(3):368-77.
    • (2007) Br J Cancer , vol.97 , Issue.3 , pp. 368-377
    • Ma, P.C.1    Tretiakova, M.S.2    Nallasura, V.3    Jagadeeswaran, R.4    Husain, A.N.5    Salgia, R.6
  • 34
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assn. 1958;53:457-81.
    • (1958) J Am Stat Assn , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 35
    • 0000336139 scopus 로고
    • Regression models and life tables (with discussion)
    • Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;187-220.
    • (1972) J R Stat Soc B , pp. 187-220
    • Cox, D.R.1
  • 37
    • 0036384579 scopus 로고    scopus 로고
    • Prognostic factors in non-small cell lung cancer: A decade of progress
    • Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 2002;122(3):1037-57.
    • (2002) Chest , vol.122 , Issue.3 , pp. 1037-1057
    • Brundage, M.D.1    Davies, D.2    Mackillop, W.J.3
  • 38
    • 64849102583 scopus 로고    scopus 로고
    • Role of c-Met in cancer: Emphasis on lung cancer
    • Salgia R. Role of c-Met in cancer: emphasis on lung cancer. Semin Oncol. 2009;36(2 suppl 1):S52-8.
    • (2009) Semin Oncol , vol.36 , Issue.2 SUPPL. 1
    • Salgia, R.1
  • 41
    • 70349475409 scopus 로고    scopus 로고
    • SATURN: A double-blind, randomized, phase III study of maintenance erlotinib versus placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC
    • Cappuzzo F. SATURN: A double-blind, randomized, phase III study of maintenance erlotinib versus placebo following nonprogression with first-line platinum-based chemotherapy in patients with advanced NSCLC. J Clin Oncol. 2009;27(suppl):15s.
    • (2009) J Clin Oncol , vol.27 , Issue.SUPPL.
    • Cappuzzo, F.1
  • 43
    • 24944468127 scopus 로고    scopus 로고
    • Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer
    • Cheng TL, Chang MY, Huang SY, Sheu CC, Kao EL, Cheng YJ, Chong IW. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer. Chest. 2005;128(3):1453-60.
    • (2005) Chest , vol.128 , Issue.3 , pp. 1453-1460
    • Cheng, T.L.1    Chang, M.Y.2    Huang, S.Y.3    Sheu, C.C.4    Kao, E.L.5    Cheng, Y.J.6    Chong, I.W.7
  • 46
    • 33847292778 scopus 로고    scopus 로고
    • From Tpr-Met to Met, tumorigenesis and tubes
    • Peschard P, Park M. From Tpr-Met to Met, tumorigenesis and tubes. Oncogene. 2007;26(9):1276-85.
    • (2007) Oncogene , vol.26 , Issue.9 , pp. 1276-1285
    • Peschard, P.1    Park, M.2
  • 47
    • 0030297898 scopus 로고    scopus 로고
    • Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development
    • Maina F, Casagranda F, Audero E, Simeone A, Comoglio PM, Klein R, Ponzetto C. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development. Cell. 1996;87(3):531-42.
    • (1996) Cell , vol.87 , Issue.3 , pp. 531-542
    • Maina, F.1    Casagranda, F.2    Audero, E.3    Simeone, A.4    Comoglio, P.M.5    Klein, R.6    Ponzetto, C.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.